id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-268952-3j43p9j3	Ueda Oshima, Masumi	Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach	2020-09-26		.txt	text/plain	3636	154	37	Situated in the initial epicenter of the pandemic, the Blood and Marrow Transplant (BMT) Program at Fred Hutchinson Cancer Research Center (Fred Hutch)/Seattle Cancer Care Alliance (SCCA) was at the forefront of delivering care to transplant patients during the surge of this public health crisis. In early March 2020 when community transmissions resulted in a steep increase of COVID-19 cases in Washington state, the individual risk for hematopoietic cell transplant (HCT) patients who acquired the infection was unknown. In early March 2020, the Institute for Health Metrics and Evaluation at the UW predicted that the COVID-19-driven demand for healthcare resources including acute and intensive care hospital beds and ventilators might exceed the available supply in Washington state and particularly in our region [6] . Once a COVID-19 vaccine is available, vaccination approaches for the posttransplant period in immunosuppressed patients, vaccination of caregivers, family, and clinical staff, and even assessing potential benefits of vaccinating donors prior to stem cell donation will have to be determined.	./cache/cord-268952-3j43p9j3.txt	./txt/cord-268952-3j43p9j3.txt